The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Spirooxindoles: Promising scaffolds for anticancer agents
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Galliford, C. V., & Scheidt, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701342 · Cited by 2,429
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Isatins As Privileged Molecules in Design and Synthesis of Spiro-Fused Cyclic Frameworks
Singh, G. S., & Desta, Z. Y. (2012) · Chemical Reviews · doi:10.1021/cr300135y · Cited by 1,601
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,328
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Enantioselective methodologies for the synthesis of spiro compounds
Rios, R. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15156h · Cited by 781
Recent Advances in Asymmetric Organocatalytic Construction of 3,3′‐Spirocyclic Oxindoles
Hong, L., & Wang, R. (2013) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201200808 · Cited by 718
Ding, K., Lu, Y., Nikolovska-Coleska, Z., Wang, G., Qiu, S., Shangary, S., Gao, W., Qin, D., Stuckey, J., Krajewski, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051122a · Cited by 702
Strategies for the enantioselective synthesis of spirooxindoles
Ball-Jones, N. R., Badillo, J. J., & Franz, A. K. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25184a · Cited by 692
Bioisosterism: A Useful Strategy for Molecular Modification and Drug Design
Lima, L., & Barreiro, E. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363540 · Cited by 672
Shangary, S., Qin, D., McEachern, D., Liu, M., Miller, R. S., Qiu, S., Nikolovska-Coleska, Z., Ding, K., Wang, G., Chen, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708917105 · Cited by 660
Structure-based design of potent non-peptide MDM2 inhibitors
Ding, K., Lu, Y., Nikolovska-Coleska, Z., Qiu, S., Ding, Y., Gao, W., Stuckey, J., Krajewski, K., Roller, P. P., Tomita, Y., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051147z · Cited by 657
Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
Ding, Q., Zhang, Z., Liu, J.-J., Jiang, N., Zhang, J., Ross, T. M., Chu, X.-J., Bartkovitz, D., Podlaski, F., Janson, C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400487c · Cited by 595
Antonchick, A. P., Gerding-Reimers, C., Catarinella, M., Schürmann, M., Preut, H., Ziegler, S., Rauh, D., & Waldmann, H. (2010) · Nature Chemistry · doi:10.1038/nchem.730 · Cited by 569
Edmondson, S., Danishefsky, S. J., Sepp-Lorenzino, L., & Rosen, N. (1999) · Journal of the American Chemical Society · doi:10.1021/ja983788i · Cited by 465
Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology
Gu, J., Gui, Y., Chen, L., Yuan, G., Lu, H.-Z., & Xu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062839 · Cited by 410
Trends in the development of chiral drugs
Caner, H., Groner, E., Levy, L., & Agranat, I. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02904-0 · Cited by 399
Zhao, Y., Yu, S., Sun, W., Liu, L., Lu, J., McEachern, D., Shargary, S., Bernard, D., Li, X., Zhao, T., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005708 · Cited by 290
Diastereomeric spirooxindoles as highly potent and efficacious MDM2 inhibitors
Zhao, Y., Liu, L., Sun, W., Lu, J., McEachern, D., Li, X., Yu, S., Bernard, D., Ochsenbein, P., Ferey, V., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3125417 · Cited by 234
Cui, C.-B., Kakeya, H., & Osada, H. (1997) · Tetrahedron · doi:10.1016/s0040-4020(96)00978-7 · Cited by 223
Current status on development of steroids as anticancer agents
Gupta, A., Sathish Kumar, B., & Negi, A. S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.011 · Cited by 216
Synthesis and Cellular Profiling of Diverse Organosilicon Small Molecules
Franz, A. K., Dreyfuss, P. D., & Schreiber, S. L. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067552n · Cited by 196
Potent and orally active small-molecule inhibitors of the MDM2-p53 interaction
Yu, S., Qin, D., Shangary, S., Chen, J., Wang, G., Ding, K., McEachern, D., Qiu, S., Nikolovska-Coleska, Z., Miller, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901400z · Cited by 180
Nardinocchi, L., Puca, R., Sacchi, A., & D'Orazi, G. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-1 · Cited by 179
Rzeski, W., Matysiak, J., & Kandefer-Szerszeń, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.041 · Cited by 176
Basic properties and molecular mechanisms of exogenous chemical carcinogens
Irigaray, P., & Belpomme, D. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp252 · Cited by 174
The Structure‐Based Design of Mdm2/Mdmx–p53 Inhibitors Gets Serious
Popowicz, G. M., Dömling, A., & Holak, T. A. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201003863 · Cited by 163
Recent Progress on Routes to Spirooxindole Systems Derived from Isatin
Xia, M., & Ma, R. (2013) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.1114 · Cited by 125
Defective DNA Strand Break Repair after DNA Damage in Prostate Cancer Cells
Fan, R., Kumaravel, T. S., Jalali, F., Marrano, P. M., Squire, J. A., & Bristow, R. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1601 · Cited by 117
Jiang, X., Sun, Y., Yao, J., Cao, Y., Kai, M., He, N., Zhang, X., Wang, Y., & Wang, R. (2012) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201100792 · Cited by 111
Iriyama, N., Yoshino, Y., Yuan, B., Horikoshi, A., Hirabayashi, Y., Hatta, Y., Toyoda, H., & Takeuchi, J. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-1 · Cited by 104
Saddler, C. M., Ouillette, P. D., Kujawski, L. A., Shangary, S. K., Talpaz, M., Kaminski, M. S., Erba, H. P., Shedden, K., Wang, S., & Malek, S. N. (2007) · Blood · doi:10.1182/blood-2007-09-112698 · Cited by 100
Zhang, Z., Chu, X., Liu, J., Ding, Q., Zhang, J., Bartkovitz, D., Jiang, N., Karnachi, P., So, S., Tovar, C., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400359z · Cited by 97
Shangary, S., Ding, K., Qiu, S., Nikolovska-Coleska, Z., Bauer, J. A., Liu, M., Wang, G., Lu, Y., McEachern, D., Bernard, D., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0140 · Cited by 91
Bacher, N., Tiefenthaler, M., Sturm, S., Stuppner, H., Ausserlechner, M. J., Kofler, R., & Konwalinka, G. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05907.x · Cited by 85
Mohammad, R. M., Wu, J., Azmi, A. S., Aboukameel, A., Sosin, A. M., Wu, S., Yang, D., Wang, S., & Al-Katib, A. M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-115 · Cited by 85
Gomez-Monterrey, I. M., Bertamino, A., Porta, A., Carotenuto, A., Musella, S., Aquino, C., Granata, I., Sala, M., Brancaccio, D., Picone, D., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100838z · Cited by 83
Small molecule modulators of protein-protein interactions: selected case studies
Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79
Canner, J. A., Sobo, M., Ball, S. L., Hutzen, B. J., Deangelis, S., Willis, W. L., Studebaker, A. W., Ding, K., Wang, S., Yang, D., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605199 · Cited by 74
Tan, W. W., Zhu, X., Zhang, S., Xing, G., Zhu, R., & Shi, F. J. (2013) · RSC Advances · doi:10.1039/c3ra40874d · Cited by 72
Cruciferous phytoalexins: antiproliferative effects in T-Jurkat leukemic cells
Pilátová, M. B., Šarišský, M., Kutschy, P., Miroššay, A., Mezencev, R., Čurillová, Z., Suchý, M., Monde, K., Mirossay, L., & Mojžíš, J. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.09.003 · Cited by 72
Synthesis and evaluation of spiroisoxazoline oxindoles as anticancer agents
Ribeiro, C. J. A., Amaral, J. D., Rodrigues, C. M. P., Moreira, R., & Santos, M. M. M. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.048 · Cited by 72
Design, synthesis and QSAR studies of dispiroindole derivatives as new antiproliferative agents
George, R. F., Ismail, N. S. M., Stawiński, J., & Girgis, A. S. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.07.035 · Cited by 69
Synthesis of novel 3′-spirocyclic-oxindole derivatives and assessment of their cytostatic activities
Yong, S. R., Ung, A. T., Pyne, S. G., Skelton, B. W., & WHITE, A. H. (2007) · Tetrahedron · doi:10.1016/j.tet.2007.04.028 · Cited by 65
Dey, S. K., Bose, D., Hazra, A., Naskar, S., Nandy, A., Munda, R. N., Das, S., Chatterjee, N., Mondal, N. B., Banerjee, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058055 · Cited by 58
Yu, B., Shi, X., Qi, P., Yu, D., & Liu, H. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.015 · Cited by 52
Self-citationSosin, A. M., Burger, A. M., Siddiqi, A., Abrams, J., Mohammad, R. M., & Al-Katib, A. M. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-57 · Cited by 42
Huang, L. Z., Zhang, X., Li, J., Ding, K., Li, X., Zheng, W., & Yin, B. (2013) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201301238 · Cited by 39
Synthetic 1,4-Pyran Naphthoquinones Are Potent Inhibitors of Dengue Virus Replication
da Costa, E. C. B., Amorim, R., da Silva, F. D. C., da Rocha, D. R., Papa, M. P., de Arruda, L. B., Mohana‐Borges, R., Ferreira, V. F., Tanuri, A., da Costa, L. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082504 · Cited by 36
Tian, Y., Nam, S., Liu, L., Yakushijin, F., Yakushijin, K., Buettner, R., Liang, W. P., Yang, F., Ma, Y., Horne, D. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049306 · Cited by 36
Sun, S. H., Zheng, M., Ding, K., Wang, S., & Sun, Y. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5841 · Cited by 36
Liu, H.-Q., Wang, D., Wu, F. P., Tang, W. F., & Ouyang, P. (2013) · Chinese Chemical Letters · doi:10.1016/j.cclet.2013.06.001 · Cited by 13
Self-citation
Cited by
Deep Eutectic Solvents: The Organic Reaction Medium of the Century
Alonso, D. A., Baeza, A., Chinchilla, R., Guillena, G., Pastor, I. M., & Ramón, D. J. (2016) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201501197 · Cited by 709
Therapeutic Potential of Spirooxindoles as Antiviral Agents
Ye, N., Chen, H., Wold, E. A., Shi, P.-Y., & Zhou, J. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00041 · Cited by 493
Catalytic asymmetric synthesis of spirooxindoles: recent developments
Mei, G.-J., & Shi, F. (2018) · Chemical Communications · doi:10.1039/c8cc02364f · Cited by 467
Stereoselective synthesis and applications of spirocyclic oxindoles
Boddy, A. J., & Bull, J. A. (2021) · Organic Chemistry Frontiers · doi:10.1039/d0qo01085e · Cited by 362
Catalytic Enantioselective Construction of Spiro Quaternary Carbon Stereocenters
Xu, P.-W., Yu, J.-S., Chen, C., Cao, Z.-Y., Zhou, F., & Zhou, J. (2019) · ACS Catalysis · doi:10.1021/acscatal.8b03694 · Cited by 325
Metadata
- Authors
- Yu, B., Yu, D.-Q., & Liu, H.-M.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 97
- Pages
- 673-698
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2949236218
- Cited by
- 867
- References
- 54
- FWCI
- 20.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.